Where does Xact Laboratories, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Xact Laboratories, LLC ranks #44,136 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Xact Laboratories, LLC hold?

Xact Laboratories, LLC holds 6 US utility patents granted between 2022 and 2025, spanning 8 technology areas.

What is Xact Laboratories, LLC's Innovation Score?

Xact Laboratories, LLC has an Innovation Score of 44.0 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Xact Laboratories, LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Xact Laboratories, LLC.

What does claim depth mean for Xact Laboratories, LLC's patents?

Xact Laboratories, LLC's patents average 12.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Xact Laboratories, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Xact Laboratories, LLC

Q: What technology areas does Xact Laboratories, LLC focus on?

Xact Laboratories, LLC's top technology area is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data) with 6 patents, ranking #792 of 3,149 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 8 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Xact ranks #44,136 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 8 technology areas.

#44,136
of 49,997 US assignees by volume: Top 27%
by Innovation Score (44.0/100): 12.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R44136 · US Corporation #44,136 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #44,136/49,997
PHOTO-FINISH Xactiv
CPC-NARROW G16H · 8 areas
INNOV-PAR 44.0/100
CLAIMS-RICH 12.2 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Xactiv, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Xact’s 44.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (15%) Velocity 20.0 pts (45%) Breadth 10.0 pts (23%) Claim depth 7.3 pts (17%)

Qualcomm Incorporated · highest

85
Xact Laboratories · this assignee

44
3D Lighting… · lowest

7

What this shows Xact's Innovation Score is 44.0/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Xact?

Each dot is one of Xact’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Xact’s own 12.2 claims/patent is at or below the 16.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Xact vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Xact's grants concentrate

Xact Laboratories, LLC is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). By volume, Xact sits between Xvivo Perfusion AB and Xeeva, Inc..

Xact's three-year grant acceleration

Xact Laboratories, LLC shows 4 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Xvivo Perfusion AB

6
Xyphos Biosciences

6
XYZ Energy Group

6
XYZ Interactive

6
Xactiv

6
Xcelemor

6
Xciel

6
Xeeva

6
Xact Laboratories ◀

6

What this shows Xact holds 6 patents at rank #44,130, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Xact

By rank, the assignees closest to #44,130 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Xact's primary technology class.

Xact's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Xact Laboratories, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	4	66.7%
2025partial year	2	33.3%

Which technologies does Xact Laboratories, LLC patent most?

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 6

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 4

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 4

H04M - Telephonic Communication 2

G06F - Electric Digital Data Processing 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Xact Laboratories, LLC's patent record in context - here's where to go next.

Xact Laboratories, LLC's lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 100% of its portfolio - see every assignee active in that class. Explore G16H
Ranked #44,136 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Xact Laboratories, LLC against Xvivo Perfusion AB, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.